首页> 外文会议>Annual conference of the International Society of Exposure Science >Identification of endocrine disrupting chemical doses in rats to reproduce human urinary metabolite concentrations
【24h】

Identification of endocrine disrupting chemical doses in rats to reproduce human urinary metabolite concentrations

机译:鉴定大鼠内分泌干扰化学剂量以复制人尿代谢产物的浓度

获取原文

摘要

We are investigating the effects of the exposure of female Sprague-Dawley rats to 3 endocrine disrupting (ED) chemicals, diethyl phthalate (DEP), methyl paraben (MPB), triclosan (TCS), and their mixture, on 6 mammary cancer susceptibility windows. The ideal animal experiment would utilize multiple chemical doses, but budgetary constraints required the choice of a single dose for each ED. Most animal studies have tested ED effects with doses that are orders of magnitude higher than common human exposure. We have conducted a dose calibration study to determine the oral dose of each ED that would result in rat urinary metabolite concentrations comparable to the concentrations reported in the general US population. We used five doses per chemical based on its NOEL (No Observed Effect Level in mg/Kg/day; MBP=1050; TCS=50; DEP=1735) plus one control group (vehicle only); 5 adult female rats per chemical/group were dosed by oral gavage for 5 days. Doses ranged from 0.0005-173 mg/kg/day. Urine and blood, collected on the last day of exposure, were analyzed for ED metabolites by solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. We used linear regression to assess relationships between oral dose and metabolite concentration. For all chemicals, the urine concentrations at the three lowest doses plus control demonstrated a very strong linear relationship (R2>0.82). NOEL/10,000 (MPB, DEP) or NOEL/1,000 (TCS) doses resulted in urinary concentrations that were within the US population concentration range. The serum concentrations did not show a clear dose response for MEP and MPB. The relationship between serum and urine concentration varied by metabolite (R2: MEP:0.085; MPB:0.58; TCS:0.93). This dose calibration study facilitated the selection of oral doses that closely mimic the exposures experience of the human population, thereby providing an opportunity to examine the effect of realistic ED exposures on genetic dysregulation in rodent mammary tissue. Supported by NIEHS/NCI: 5U01ES019459.
机译:我们正在研究将雌性Sprague-Dawley大鼠暴露于3种内分泌干扰物(ED)化学品,邻苯二甲酸二乙酯(DEP),对羟基苯甲酸甲酯(MPB),三氯生(TCS)及其混合物对6种乳腺癌易感性窗口的影响。理想的动物实验将使用多个化学剂量,但是预算限制要求为每个ED选择单个剂量。大多数动物研究都以比普通人类暴露量高几个剂量的剂量测试了ED的作用。我们进行了剂量校准研究,以确定每种ED的口服剂量,这些剂量将导致大鼠尿代谢产物的浓度与美国普通人群中报告的浓度相当。我们根据每种化学药品的NOEL(无可观察到的影响水平,以mg / Kg /天为单位; MBP = 1050; TCS = 50; DEP = 1735)使用了五种剂量,再加上一个对照组(仅用于车辆);每个化学药品/组5只成年雌性大鼠通过管饲法给药5天。剂量范围为0.0005-173 mg / kg /天。在暴露的最后一天收集的尿液和血液通过固相萃取-高效液相色谱-同位素稀释串联质谱法分析ED代谢产物。我们使用线性回归来评估口服剂量和代谢物浓度之间的关系。对于所有化学药品,三个最低剂量加上对照组的尿液浓度都显示出非常强的线性关系(R2> 0.82)。 NOEL / 10,000(MPB,DEP)或NOEL / 1,000(TCS)剂量导致尿液浓度在美国人口浓度范围内。血清浓度对MEP和MPB没有明显的剂量反应。血清和尿液浓度之间的关系因代谢产物而异(R2:MEP:0.085; MPB:0.58; TCS:0.93)。这项剂量校准研究有助于选择与人类的暴露经验极为相似的口服剂量,从而为检查实际ED暴露对啮齿动物乳腺组织遗传失调的影响提供了机会。由NIEHS / NCI支持:5U01ES019459。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号